Immediate post-operative brachytherapy prior to irradiation and temozolomide for newly diagnosed glioblastoma

By Waters J.  

Journal of Neuro-Oncology, Vol. 113, Iss. 3, 2013-07 ,pp. : 467-477

Springer Publishing Company

Access to resources Recommend Favorite

Treatment of Newly Diagnosed Glioblastoma with Concomitant and Adjuvant Temozolomide and Radiotherapy: UK Experience

By Beresford Mark J.   Power Danielle   Alexander Emma   Brock Cathryn   Thompson Julian   Roncaroli Federico   Waldman Adam D.   James van Dellen   Glaser Mark  

American Journal of Cancer, Vol. 5, Iss. 6, 2006-01 ,pp. : 427-432

Adis International

Access to resources Recommend Favorite

Cilengitide treatment of newly diagnosed glioblastoma patients does not alter patterns of progression

By Eisele Günter   Wick Antje   Eisele Anna-Carina   Clément Paul   Tonn Jörg   Tabatabai Ghazaleh   Ochsenbein Adrian   Schlegel Uwe   Neyns Bart   Krex Dietmar   Simon Matthias   Nikkhah Guido   Picard Martin   Stupp Roger   Wick Wolfgang   Weller Michael  

Journal of Neuro-Oncology, Vol. 117, Iss. 1, 2014-03 ,pp. : 141-145

Springer Publishing Company

Access to resources Recommend Favorite

Temozolomide in glioblastoma: results of administration at first relapse and in newly diagnosed cases. Is still proposable an alternative schedule to concomitant protocol?

By Caroli Manuela   Locatelli Marco   Campanella Rolando   Motta Federica   Mora Annarita   Prada Francesco   Borsa Stefano   Martinelli-Boneschi Filippo   Saladino Andrea   Gaini Sergio  

Journal of Neuro-Oncology, Vol. 84, Iss. 1, 2007-08 ,pp. : 71-77

Springer Publishing Company

Access to resources Recommend Favorite

Integration of autologous dendritic cell-based immunotherapy in the primary treatment for patients with newly diagnosed glioblastoma multiforme: a pilot study

By Ardon Hilko   Gool Stefaan   Lopes Isabel   Maes Wim   Sciot Raf   Wilms Guido   Demaerel Philippe   Bijttebier Patricia   Claes Laurence   Goffin Jan   Calenbergh Frank   Vleeschouwer Steven  

Journal of Neuro-Oncology, Vol. 99, Iss. 2, 2010-09 ,pp. : 261-272

Springer Publishing Company

Access to resources Recommend Favorite